LINDA JOHNSON: Open Payments
NPI 1912398934 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 12 payments from 9 companies in 2025. Trend: 2023 $225 · 2024 $535 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $228 |
| Neurocrine BioSciences, Inc. | 1 | $129 |
| Insulet Corporation | 1 | $124 |
| MERZ NORTH AMERICA, INC. | 1 | $124 |
| Abbott Laboratories | 1 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $83 |
| Amgen Inc. | 1 | $80 |
| PFIZER INC. | 1 | $17 |
Products named: BREZTRI, Omnipod, Xeomin, FREESTYLE LIBRE 3, Kerendia, JARDIANCE, OTEZLA, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
